12 completed, 2 recruiting, 2 terminated, 2 unknown. 18 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 18 | Completed 12, Recruiting 2, Terminated 2, Unknown 2 |
Follow Impulsive Behavior: new trials by email Literature Review of Impulsive Behavior trials Research Report on Impulsive Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin for Methamphetamine Addiction Psilocybin 25 mg - Methamphetamine Use Disorder | Early Phase 1 | Recruiting | Kevin Murnane | 20 | 2025-04-04 | 2025-10-07 |
| Impulsivity Domains and Subjective Response Placebo, Alcohol - Alcohol Use Disorder | Early Phase 1 | Recruiting | Jessica Weafer | 250 | 2024-04-01 | 2026-05-22 |
| mHealth to Help Pregnant and Postpartum Women in Recovery for Opioid Use Disorder uMAT-R mobile app with coaching component - Opioid Use Disorders | Early Phase 1 | Completed | Washington University School of Medicine | 125 | 2023-07-01 | 2026-04-03 |
| Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine CBD Day 1, CBD Day 2, CBD Day 3 - Addiction | Early Phase 1 | Completed | Yale University | 7 | 2021-12-08 | 2025-11-26 |
| Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder Probiotic Formula lacteal forte - Inattentive, Hyperactivity | Early Phase 1 | Completed | Ain Shams University | 80 | 2020-06-09 | 2022-12-27 |
| Lorcaserin for Cannabis Use Disorder Lorcaserin, Placebo oral capsule - Cannabis Use Disorder | Early Phase 1 | Terminated | New York State Psychiatric Institute | 5 | 2019-08-01 | 2021-01-28 |
| Impulsivity and Alcohol Response Alcohol - Alcohol Use Disorder (AUD), Subjective Response to Alcohol (SR) | Early Phase 1 | Terminated | University of Florida | 24 | 2019-05-01 | 2023-12-06 |
| Nicotine TMS EFT Smoking Pilot Study Real cTBS, Sham cTBS - Smoking, Nicotine Dependence | Early Phase 1 | Completed | Medical University of South Carolina | 16 | 2018-05-22 | 2019-08-14 |
| Oxytocin and Cognitive Control in Adult ADHD Oxytocin nasal spray, Placebo nasal spray - Attention Deficit/Hyperactivity Disorder | Early Phase 1 | Completed | Massachusetts General Hospital | 24 | 2017-12-14 | 2024-05-03 |
| Motivation and Methylphenidate Ritalin (methylphenidate)10Mg Tablet, Placebo Oral Tablet - Motivation, Apathy | Early Phase 1 | Completed | Institut National de la Santé Et de la Recherche Médicale, France | 35 | 2017-07-11 | 2026-04-24 |
| Reducing the Abuse Liability of Prescription Opioids Risperidone, Ziprasidone, Oxycodone - Addiction | Early Phase 1 | Completed | The University of Texas Health Science Center at San Antonio | 15 | 2017-06-16 | 2020-10-14 |
| Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder Topiramate and N-Acetyl Cysteine, Topiramate and Placebo - Alcoholism | Early Phase 1 | Completed | Nassima Ait-Daoud Tiouririne | 17 | 2017-05-01 | 2026-05-27 |
| Behavioral Effects of Pregabalin and Cannabis Pregabalin, Placebo - Cannabis-use Disorders | Early Phase 1 | Completed | Joshua A. Lile, Ph.D. | 30 | 2017-02-01 | 2021-09-10 |
| Cortical rTMS as a Tool to Change Brain Reactivity to Alcohol Cues medial prefrontal cortex, dorsolateral prefrontal cortex, sham - Alcohol Dependance | Early Phase 1 | Completed | Medical University of South Carolina | 71 | 2016-01-01 | 2022-01-13 |
| Theta Burst TMS as a Tool to Change Smoking Behavior continuous theta burst stimulation (real), continuous theta burst stimulation (sham) - Smoking, Addiction | Early Phase 1 | Completed | Medical University of South Carolina | 15 | 2015-10-01 | 2018-07-23 |
| Gut Hormones in Obesity, Nicotine and Alcohol Dependence Exenatide, Desacyl ghrelin, Saline - Obesity, Smoking Cessation | Early Phase 1 | Unknown | Imperial College London | 95 | 2015-08-01 | 2020-02-13 |
| Deep Brain Stimulation of the Nucleus Accumbens as a Novel Treatment in Severe Opioid Addiction Deep brain stimulation, Placebo - Addiction | Early Phase 1 | Unknown | Jens Kuhn | 10 | 2011-01-01 | 2016-12-07 |
| Stress, Hormones, and Eating Naltrexone, Placebo - Food Addiction, How Opioid Tone Was Related to Self Reported | Early Phase 1 | Completed | University of California, San Francisco | 42 | 2010-07-01 | 2021-01-28 |
Behavior, Addictive (12) · Alcoholism (4) · Marijuana Abuse (2) · Obesity (2) · Smoking (2) · Substance-Related Disorders (2) · Attention Deficit Disorder with Hyperactivity (1) · Cigarette Smoking (1) · Food Addiction (1) · Lethargy (1) · Opioid-Related Disorders (1) · Smoking Cessation (1) · Spasm (1) · Tobacco Use Disorder (1)
Behavior (18) · Compulsive Behavior (13) · Mental Disorders (11) · Chemically-Induced Disorders (9) · Substance-Related Disorders (7) · Alcohol-Related Disorders (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Body Weight (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Nutrition Disorders (2) · Nutritional and Metabolic Diseases (2) · Overnutrition (2)
Ethanol (2) · Sodium Chloride (2) · Acetylcysteine (1) · Deep Brain Stimulation (1) · Exenatide (1) · Methylphenidate (1) · Naltrexone (1) · Oxycodone (1) · Pregabalin (1) · Psilocybin (1) · Risperidone (1) · Sugars (1) · Topiramate (1) · ghrelin, des-n-octanoyl (1) · lorcaserin (1)
Medical University of South Carolina (3) · Ain Shams University (1) · Imperial College London (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · Jens Kuhn (1) · Jessica Weafer (1) · Joshua A. Lile, Ph.D. (1) · Kevin Murnane (1) · Massachusetts General Hospital (1) · Nassima Ait-Daoud Tiouririne (1) · New York State Psychiatric Institute (1) · The University of Texas Health Science Center at San Antonio (1) · University of California, San Francisco (1) · University of Florida (1) · Washington University School of Medicine (1)
United States (13) · Egypt (1) · France (1) · Germany (1) · United Kingdom (1)
Christina Brezing, MD (1) · Colleen A Hanlon, Ph.D. (1) · Colleen A Hanlon, PhD (1) · David Nutt, MD, PhD (1) · Elissa Epel, PhD (1) · Elizabeth A Lawson, MD (1) · James Prisciandaro, Ph.D. (1) · Jens Kuhn, MD (1) · Jessica Weafer, PhD (1) · Joao De Aquino, M.D. (1) · Joshua A. Lile, Ph.D. (1) · Kevin S Murnane, PhD (1) · Max Eckmann, MD (1) · Nassima Ait-Daoud Tiouririne, M.D. (1) · Reham Ibrahim (1)
K23DA052682 (1), P50AA010761 (1), R01AA029488 (1), R34DA050453 (1), T32AA025877 (1)